Bookmark list

Takeda to Acquire Syrrx

09-Feb-2005

Takeda Pharmaceutical Company Limited announced that Takeda and Syrrx Inc. agreed on February 5, 2005 (PST) to merge Syrrx, Inc. into the Takeda Group. The merger is subject to clearance under the Hart-Scott-Rodino Antitrust Improvements Act and is subject to the satisfaction of other customary closing conditions. Upon successful completion of the transaction, which is anticipated to occur in the first quarter of 2005, Syrrx will become a subsidiary of Takeda America Holdings, Inc., a wholly owned subsidiary of Takeda.

This merger will integrate Syrrx's technologies and R&D pipeline into Takeda and establish a discovery research presence for Takeda in the US. This relationship is expected to help Takeda further enhance its R&D pipeline and to create more innovative drugs as early as possible through efficient discovery processes including identification of target molecules, search for hit compounds and medicinal chemistry research. Syrrx will become part of Takeda's global discovery research network together with Takeda's existing discovery centers in Osaka and Tsukuba, Japan.

Syrrx achieves a competitive advantage in drug discovery by leveraging its leading high-throughput X-ray crystallography capabilities to determine the three dimensional structures of drug targets. Syrrx uses these structures to efficiently design best-in-class drug candidates. Syrrx irects its efforts toward therapeutics to treat metabolic diseases, cancer, and inflammation, and has multiple R&D pipeline products including several compounds directed to type 2 diabetes already in clinical development.

https://www.chemeurope.com/en/news/43291/takeda-to-acquire-syrrx.html

Get the chemical industry in your inbox

Takeda to Acquire Syrrx

Other news from the department business & finance

Porsche may acquire stake in Varta and majority stake in e-mobility division "V4Drive"

Start-up Mechanolution wants to revolutionize the chemical industry

New Global CEO for CREMER OLEO

Neste and Braskem announce agreement on supply of renewable and recycled feedstocks for polymers and chemicals production

autarkize raises €2.3 million in seed funding to drive sustainable energy transition

Mercedes-Benz opens own recycling factory to close the battery loop

Major investment boosts next-generation 3D printing technology

Merck Reiterates Confidence in Returning to Sustainable Growth

Evonik aligns two business lines with new growth strategy

Start-up aims to revolutionise CO₂ capture and conversion technology

UK bioplastics breakthrough wins US plastics industry prize

Start-up in the fight against "forever chemicals": revolutionary technology completely destroys PFAS

Integrals Powers makes energy density breakthrough in Lithium Manganese Iron Phosphate cell chemistry

LANXESS signs contract to sell Urethane Systems business to UBE Corporation

Covestro signs an Investment Agreement with ADNOC

Stahl completes acquisition of WEILBURGER Graphics

Revolutionary Textile Membrane for a More Sustainable Outdoor Clothing Industry

Start-up wants to revolutionise fluorochemical production

BASF presents new corporate strategy

eMolecules acquires Synple Chem AG

Get the chemical industry in your inbox

Most read news

Magnetism without metal: a milestone for materials science

Start-up aims to revolutionise CO₂ capture and conversion technology

Flower Power: Lavender Oil Fuels Batteries for the Future

Octopus-inspired adhesive works well in wet conditions

A “chemical ChatGPT” for new medications

Are trees the future for the production of industrial chemicals?

Cobalt-copper tandem successfully converts carbon dioxide to ethanol

UK bioplastics breakthrough wins US plastics industry prize

No significant PFAS emissions from waste incineration

Innovative catalyst produces methane using electricity

The fireproof battery

Scientists develop novel method for strengthening PVC products

More news from our other portals

Is the physics of red blood cells in bats a key to "artificial hibernation" for humans?

Fasting and blood sugar

New test improves diagnosis of allergies

New drugs from toxic birds

Solein® tops the list of NASA’s alternatives for space food systems

Kaspar Hauser was 99.9994 percent not a prince

Microbe of the Year 2023: Bacillus subtilis – for health and technology

Precise and fast kokumi effect

New insights into the genetics of the common octopus: genome at the chromosome level decoded

Possible trigger of Crohn’s disease discovered

Ferments du Futur: New Innovation Center for Future Foods Opens

“The integration of robotics and AI is poised to revolutionize science labs”

Nobel Prize in Physiology or Medicine for the discovery of microRNA

Delicious and plant-based: the new EXTRA plant-based chewing gum

Are tattoos safe?

ONE microscopy: from molecule to 3D structure with conventional microscopy

1.3 million pizzas with solar power

Start-up receives funding for animal-free methods for drug testing

Protein interactions: who is partying with whom and who is ruining the party?

When it comes to building muscle, not all proteins are created equal

Cost-effective modular system for optical imaging from the 3D printer

Superspreader fibrils caught in the act

Children, pregnant women and breastfeeding mothers should avoid Brazil nuts

Drug discovery within the patient

The preparation makes the poison

Full-bodied cheese flavor–prediction of flavor development soon possible thanks to new method

AI does not necessarily lead to more efficiency in clinical practice

Stardust in the bathroom

Victory against fast food giants

Automated analysis of German insect diversity

So close that even molecules turn red...

So close that even
molecules turn red...